SEATTLE, May 10, 2021, (MEDGADGET) — Overview
Anti-inflammatory drugs are a class of analgesics, which are used to treat various inflammatory disorders. These medicines are used to relieve pain, reduce inflammation, or treat fever. These drugs are used globally on prescriptions as well as off label on tablets, pills, creams, liquids, injections, sprays, and suppositories. However, an increase in chronic and incurable diseases is expected to boost global anti-inflammatory drugs market growth. For instance, according to an article published by National Kidney Foundation Inc. in November 2019, it reports that the incidence of inflammatory diseases in the U.S. has doubled since the 1990s and is now estimated at 3.9% of the 8.3 million people in U.S. gout, among them 6.1 million men and 2.2 million women.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/4327
The global anti-inflammatory drugs market is estimated to cost US$ 79,830.2 million by 2020 and is expected to show a CAGR of 8.6% over the period (2020-2027).
Global Anti-inflammatory Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus epidemic (COVID-19) and the lockdowns of various countries around the world have impacted on the financial situation of businesses in all sectors. Private health care is one such sector that is most affected by the COVID-19 epidemic.
Unemployment in various countries due to the epidemic has put economic strain on the healthcare sector. However, the coronavirus epidemic has disrupted the development, production, and supply of drugs and other health products and has affected growth of health care businesses in various companies around the world.
As a result, the impact of the COVID-19 epidemic is also expected to limit growth of the global anti-inflammatory drugs market during the forecast period.
Drivers
Ongoing research and development of anti-inflammatory drugs is expected to drive growth of the global anti-inflammatory drugs market.
Further research and development followed by the approval and introduction of anti-inflammatory drugs is expected to boost global anti-inflammatory drugs market growth over the forecast period. For instance, in April 2020, InDex Pharmaceuticals Holding AB, received positive responses from the U.S. The Food and Drug Administration (U.S. FDA) and the European Medicines Agency (EMA) for phase III testing of TLR9 agonist cobitolimod. The drug is a potential new drug for patients with moderate to severe ulcerative colitis, an incurable intestinal disease.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4327
Restraints
The failure of drug effects in clinical trials is expected to hamper global anti-inflammatory drugs market growth over the forecast period. For instance, in July 2020, F. Hoffmann-La Roche AG, an international health company has announced that its COVACTA trial of Actemra (tocilizumab), an anti-inflammatory drug, has failed to achieve its initial development. The drug was supposed to support patients hospitalized with severe pneumonia COVID-19 although it failed as it proved ineffective and failed to improve outcomes in the disease.
Regional Analysis
The increase in the incidence of serious and chronic diseases in North America is expected to propel the global anti-inflammatory drugs market growth.
North America is expected to witness significant growth of the global anti-inflammatory drugs market, due to an increase in new cases of serious and chronic diseases in the region. For instance, according to an article published by the Arthritis Foundation in 2017, it reports that the number of adults in the U.S. Arthritis is expected to increase by 49% to 78.4 million (25.9% of all adults) by 2040.
Market Segmentation
- By Drug Type:Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Anti-inflammatory Biologics, Corticosteroids.
- By Application:Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Gout, Others.
- By Route of Administration:Oral, Topical, Injection, and Inhalation.
- By Distribution Channel:Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4327
Key Players
Major players working in the global anti-inflammatory drugs market Such as Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Amgen, Inc., Merck & Company, Inc., Johnson & Johnson Services Inc., AstraZeneca plc, Eli Lily and Company, F. Hoffmann-La Roche AG, AbbVie Inc., Sun Pharmaceutical Industries Ltd, Bristol Myers Squibb Company, Biogen Inc., Mylan, Inc., Dr. Reddy’s Laboratories, and Aurobindo Pharma Limited.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
- Market Dynamics
- Global Anti-inflammatory Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Market Scenario
- Impact of COVID-19 Market on the Anti-inflammatory Drugs Products
- Global Anti-inflammatory Drugs Market, By Drug Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Anti-inflammatory Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Anti-inflammatory Drugs Market, By Application, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Arthritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Inflammatory Bowel Disease (IBD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Gout
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Anti-inflammatory Drugs Market, By Route of Administration, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Anti-inflammatory Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Anti-inflammatory Drugs Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837